相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systemic AAV6-synapsin-GFP administration results in lower liver biodistribution, compared to AAV1&2 and AAV9, with neuronal expression following ultrasound-mediated brain delivery
Danielle Weber-Adrian et al.
SCIENTIFIC REPORTS (2021)
Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Muller glial, and PAX6 cells
Andrea J. Korecki et al.
GENE THERAPY (2021)
Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System
Adriana Galvan et al.
HUMAN GENE THERAPY (2021)
Synapsin-caveolin-1 gene therapy preserves neuronal and synaptic morphology and prevents neurodegeneration in a mouse model of AD
Shanshan Wang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Ly6a Differential Expression in Blood-Brain Barrier Is Responsible for Strain Specific Central Nervous System Transduction Profile of AAV-PHP.B
Ana Rita Batista et al.
HUMAN GENE THERAPY (2020)
Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery
Michael J. Castle et al.
HUMAN GENE THERAPY (2020)
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Helena Costa Verdera et al.
MOLECULAR THERAPY (2020)
Focused ultrasound delivery of a selective TrkA agonist rescues cholinergic function in a mouse model of Alzheimer's disease
K. Xhima et al.
SCIENCE ADVANCES (2020)
Clinically approved IVIg delivered to the hippocampus with focused ultrasound promotes neurogenesis in a model of Alzheimer's disease
Sonam Dubey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Muller glia
Yacine Touahri et al.
THERANOSTICS (2020)
Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound
Mihaela Stavarache et al.
JOURNAL OF NEUROSURGERY (2019)
New MiniPromoter Ple345 (NEFL) Drives Strong and Specific Expression in Retinal Ganglion Cells of Mouse and Primate Retina
Elizabeth M. Simpson et al.
HUMAN GENE THERAPY (2019)
The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier
Juliette Hordeaux et al.
MOLECULAR THERAPY (2019)
AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neonate Pompe Mice
Pasqualina Colella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Intravenous Injection of an AAV-PHP.B Vector Encoding Human Acid α-Glucosidase RescuesBoth Muscle and CNS Defects in Murine Pompe Disease
Jeong-A Lim et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids
Qin Huang et al.
PLOS ONE (2019)
AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity
Defne A. Amado et al.
MOLECULAR THERAPY (2019)
Strategy to enhance transgene expression in proximity of amyloid plaques in a mouse model of Alzheimer's disease
Danielle Weber-Adrian et al.
THERANOSTICS (2019)
Vector uncoating limits adenoassociated viral vector-mediated transduction of human dendritic cells and vector immunogenicity
Axel Rossi et al.
SCIENTIFIC REPORTS (2019)
The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
Juliette Hordeaux et al.
MOLECULAR THERAPY (2018)
Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain
Yasunori Matsuzaki et al.
NEUROSCIENCE LETTERS (2018)
Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound
Nir Lipsman et al.
NATURE COMMUNICATIONS (2018)
Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease A Randomized Clinical Trial
Michael S. Rafii et al.
JAMA NEUROLOGY (2018)
Gene Therapy with Regulatory T Cells: A Beneficial Alliance
Moanaro Biswas et al.
FRONTIERS IN IMMUNOLOGY (2018)
AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
Jonathan B. Rosenberg et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2018)
Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After Trial
Celine Vandamme et al.
HUMAN GENE THERAPY (2017)
Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy
Hildegund C. J. Ertl et al.
HUMAN GENE THERAPY (2017)
Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
Ken Y. Chan et al.
NATURE NEUROSCIENCE (2017)
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
J. R. Mendell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models
Elizabeth E. Spangenberg et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator
Wei Duan et al.
MOLECULAR NEUROBIOLOGY (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Benjamin E. Deverman et al.
NATURE BIOTECHNOLOGY (2016)
rAAV-compatible MiniPromoters for restricted expression in the brain and eye
Charles N. de Leeuw et al.
MOLECULAR BRAIN (2016)
PAX6 MiniPromoters drive restricted expression from rAAV in the adult mouse retina
Jack W. Hickmott et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Organization, evolution and functions of the human and mouse Ly6/uPAR family genes
Chelsea L. Loughner et al.
HUMAN GENOMICS (2016)
Gene delivery to the spinal cord using MRI-guided focused ultrasound
D. Weber-Adrian et al.
GENE THERAPY (2015)
Transduction of antigen-presenting cells in the brain by AAV9 warrants caution in preclinical studies
John Forsayeth et al.
MOLECULAR THERAPY (2015)
Nerve Growth Factor Gene Therapy Activation of Neuronal Responses in Alzheimer Disease
Mark H. Tuszynski et al.
JAMA NEUROLOGY (2015)
Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus
S. Wang et al.
GENE THERAPY (2015)
AAV9-mediated Expression of a Non-self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-presenting Cell Transduction
Lluis Samaranch et al.
MOLECULAR THERAPY (2014)
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre
Jon B. Toledo et al.
BRAIN (2013)
Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound
Jessica F. Jordao et al.
EXPERIMENTAL NEUROLOGY (2013)
Cerebral Infusion of AAV9 Vector-encoding Non-self Proteins Can Elicit Cell-mediated Immune Responses
Agnieszka Ciesielska et al.
MOLECULAR THERAPY (2013)
Targeted Delivery of Self-Complementary Adeno-Associated Virus Serotype 9 to the Brain, Using Magnetic Resonance Imaging-Guided Focused Ultrasound
Emmanuel Thevenot et al.
HUMAN GENE THERAPY (2012)
Blood-Brain Barrier: Real-time Feedback-controlled Focused Ultrasound Disruption by Using an Acoustic Emissions-based Controller
Meaghan A. O'Reilly et al.
RADIOLOGY (2012)
Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
Steven J. Gray et al.
MOLECULAR THERAPY (2011)
Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS
M. A. Zanta-Boussif et al.
GENE THERAPY (2009)
Transduction of Nonhuman Primate Brain with Adeno-Associated Virus Serotype 1: Vector Trafficking and Immune Response
Piotr Hadaczek et al.
HUMAN GENE THERAPY (2009)
Adeno-Associated Virus-Mediated Gene Transfer to Nonhuman Primate Liver Can Elicit Destructive Transgene-Specific T Cell Responses
Guangping Gao et al.
HUMAN GENE THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Complement is an essential component of the immune response to adeno-associated virus vectors
Anne K. Zaiss et al.
JOURNAL OF VIROLOGY (2008)
Investigations of combinations of mutations in the jellyfish green fluorescent protein (GFP) that afford brighter fluorescence, and use of a version (VisGreen) in plant, bacterial, and animal cells
Prapapan Teerawanichpan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2007)
Evidence for a wide extra-astrocytic distribution of S100B in human brain
Johann Steiner et al.
BMC NEUROSCIENCE (2007)
Complement-mediated activation of the adaptive immune responses - Role of C3d in linking the innate and adaptive immunity
Franklin R. Toapanta et al.
IMMUNOLOGIC RESEARCH (2006)
A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
MH Tuszynski et al.
NATURE MEDICINE (2005)
Neuronal nuclear antigen (NeuN): A new tool in the diagnosis of central neurocytoma
F Soylemezoglu et al.
PATHOLOGY RESEARCH AND PRACTICE (2003)
Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits
K Hynynen et al.
RADIOLOGY (2001)
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
MA Chishti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
